Tyler Robin, M.D., Ph.D., University of Colorado Anschutz Medical Campus (IMAGE)

University of Colorado Anschutz

Tyler Robin, M.D., Ph.D., University of Colorado Anschutz Medical Campus

Caption

Tyler Robin, M.D., Ph.D. and colleagues show that immunotherapies may combine well with radiosurgery against melanoma with brain metastases, and that anti-PD-1/PD-L1 therapies may work better than anti-CTLA4 therapies in this setting.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.